PTPI - Petros Pharmaceuticals, Inc. Quarterly EPS earnings growth

Symbol and logo of brand Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals (PTPI) price action is tied to the approval of over-the-counter status for its primary men's product amid borderline financial stability. The quarterly EPS growth trend illustrates profit adaptation to regulation, where 0.00 serves as the final level marker. The business model relies on CMO contract manufacturing, while the environmental strategy is based on zero-waste synthesis and strict control of chemical disposal in laboratories.

Petros Pharmaceuticals, Inc. (PTPI) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 06/28/2025

Analytical breakdowns for Petros Pharmaceuticals

- share price and expert price forecast:
Fundamental company valuation:Petros Pharmaceuticals
Flagship merchandise of petrospharma.com

For Petros Pharmaceuticals (PTPI), which is developing affordable men's health solutions, analyzing earnings per share (EPS) dynamics allows for an assessment of the monetization efficiency of over-the-counter drugs. The current quarterly EPS growth value of 0.00 reflects the percentage change in net income per share compared to the same period last year, demonstrating the business's actual speed of liquidity generation.

Who Petros Pharmaceuticals competes with

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|ENTX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months MindWalk Holdings, Inc. HYFT|Quarterly EPS earnings growth abvcpharma.com ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QNTM|FGEN (FibroGen Corporation) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Telomir Pharma|Year-over-year net earnings per share growth for the last 12 months RANI|Earnings per share growth in annualized terms for the last twelve months synergychc.com SNYR|Year-over-year earnings per share growth for the last twelve months Rallybio Corp (RLYB)|LEXX - Earnings per share growth in annualized terms for the last twelve months|Pulmatrix Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTHL|Aptorum Group Ltd - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Lyra Therapeutics LYRA|IBO: Quarterly EPS earnings growth|TNFA (TNF Pharma) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months cbdmd.com|Year-over-year earnings per share growth for the last 12 months PRFX (PainReform Corp)|Quarterly EPS earnings growth CYTO|Year-over-year net earnings per share growth for the last 12 months Lipella Pharmaceuticals LIPO|Year-over-year earnings per share growth for the last twelve months OptiNose OPTN|Pieris Pharmaceuticals Inc - Year-over-year earnings per share growth for the last twelve months|Procaps Group Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)